✦ LIBER ✦

Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia

✍ Scribed by K. Bronnick; D. Aarsland; J. P. Larsen

Book ID: 109340901
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 106 KB
Volume: 112
Category: Article
ISSN: 0001-690X
DOI: 10.1111/j.1600-0447.2005.00562.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and correlates of neuropsychi

Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

✍ Jaime Kulisevsky; Javier Pagonabarraga; Berta Pascual-Sedano; Carmen García-Sánc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract A cross‐sectional study of the profile of psychiatric symptoms and their relationships to medications, executive performance, and excessive daytime somnolence (EDS) was conducted on 1351 consecutive Parkinson's disease patients without dementia (PD‐ND). Ratings were: neuropsychiatric in

Frequency of dementia, depression, and o

Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease

✍ Oliver Riedel; Jens Klotsche; Annika Spottke; Günther Deuschl; Hans Förstl; Frit 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Fluctuating cognition and different cogn

Fluctuating cognition and different cognitive and behavioural profiles in Parkinson’s disease with dementia: comparison of dementia with Lewy bodies and Alzheimer’s disease

✍ Sara Varanese; Bernardo Perfetti; Daniela Monaco; Astrid Thomas; Laura Bonanni; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 321 KB

Pharmacokinetics and clinical efficacy o

Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: A study of five different suppositories

✍ Dr. T. van Laar; E. N. H. Jansen; C. Neef; M. Danhof; R. A. C. Roos 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

## Abstract The pharmacokinetics and clinical effects of apomorphine after rectal administration were determined in five patients with idiopathic Parkinson's disease (PD). Three different pharmaceutical formulations were tested: a rectal solution of apomorphine (10 or 15 mg), a gelatin suppository